Top Stories
-
The event, co-hosted by the HICCC, featured poster presentations of 100 research abstracts
Topic
-
Source:
CUIMC NewsroomSadelain, a physician-scientist known for breakthrough work on CAR-T therapy, will lead a new cell engineering and therapy initiative at Columbia
Topic
-
The V Foundation Translational grant supports Dr. Wechsler-Reya's innovative research in identifying new targets and potential therapies for pediatric brain tumors.
Topic
-
Ben Izar, MD, PhD, joins this cohort with an award of $1.25 million to continue the transformative work in his lab to enhance T cell function in cancer immunotherapy.
Topic
Latest News
- January 26, 2022
Michael Shen, PhD, the Arthur J. Antenucci Professor of Medical Sciences, has been elected to the 2021 class of new fellows of the American Association for the Advancement of Science (AAAS).
- January 24, 2022
Dr. Barbara Pro, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at the Herbert Irving Comprehensive Cancer Center (HICCC).
Topic
- December 15, 2021
The new Center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.
Topic
